Linked Life Data

8240998

Source:http://linkedlifedata.com/resource/pubmed/id/8240998

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
8
pubmed:dateCreated
1994-1-4
pubmed:abstractText
A phase I study with topotecan (SKF 104864-A, NSC 609699), a semisynthetic analog of camptothecin, was performed using a daily-times-5 regimen, given i.v. q 3 weeks, to evaluate the pharmacokinetics and toxicities of the compound.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
673-8
pubmed:dateRevised
2010-11-18
pubmed:meshHeading
pubmed:year
1993
pubmed:articleTitle
Phase I and pharmacokinetics study of topotecan, a new topoisomerase I inhibitor.
pubmed:affiliation
Dept. of Medical Oncology, Rotterdam Cancer Institute, The Netherlands.
pubmed:publicationType
Journal Article, Clinical Trial, Clinical Trial, Phase I